Indian Mesalamine Exporters: Complete Supplier Ranking with Market Share — 214 Manufacturers (2026) — TransData Nexus

Q: Who is the largest mesalamine buyer importing from India?

EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) is the largest mesalamine importer from India with a 81.0% market share and import value of $1.1B.

Q: How many mesalamine buyers import from India?

There are 214 active mesalamine buyers importing from India, with a combined import market of $1.3B across 3,779 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top mesalamine buyers from India?

The top 5 mesalamine buyers — EVERSANA LIFE SCIENCE SERVICES, SUN PHARMACEUTICAL INDUSTRIES, INC., NORTHSTAR DISTRIBUTION CENTER 8912, SUN PHARMACEUTICAL INDUSTRIES INC, EVERSANA LIFE SCIENCE SERVICES, — together control 94.7% of total mesalamine import value from India.

Suresh Sormare

Mesalamine

India Pharmaceutical Trade Intelligence

$1.3B103 Suppliers51 CountriesHS 30049099

ExportsIndia → UNITED STATES98.6%India → RUSSIA0.4%

ImportsUNITED STATES → India$1.0M ISRAEL → India$27.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $1.3B through 563 shipments. This represents a market share of 98.6% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• EVERSANA LIFE SCIENCE SERVICES - $1.1B (82.1% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES, INC. - $148.6M (11.4% of country's total business)

• NORTHSTAR DISTRIBUTION CENTER 8912 - $13.1M (1.0% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES INC - $11.5M (0.9% of country's total business)

• EVERSANA LIFE SCIENCE SERVICES, - $8.5M (0.7% of country's total business)

• Rest of United States's importers - $51.4M (3.9% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $2.3M, indicating premium pricing strategy compared to the market average of $349.1K.

United States is a key market for Mesalamine imports, representing 98.6% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Mesalamine buyer market intelligence

1Buyer Segment Analysis

The 214 buyers of Mesalamine from India can be categorized into the following segments:

1. Distributors: Entities that purchase Mesalamine in bulk to supply to various healthcare providers.

*Examples*: EVERSANA LIFE SCIENCE SERVICES (United States, $1,068.08M), NORTHSTAR DISTRIBUTION CENTER 8912 (United States, $13.12M).

*Buying Behavior*: Distributors typically place large, regular orders to maintain a steady supply chain, ensuring availability for their clients.

2. Pharmaceutical Companies: Manufacturers that procure Mesalamine for formulation into finished products.

*Examples*: SUN PHARMACEUTICAL INDUSTRIES, INC. (United States, $148.57M), AO RANBAXY (Russia, $2.94M).

*Buying Behavior*: These companies may have variable order patterns, aligning purchases with production schedules and market demand.

3. Re-exporters: Companies that import Mesalamine for the purpose of exporting to other markets.

*Examples*: AO "RANBAXY" (Russia, $2.16M).

Country-Specific Import Regulations

TransData Nexus Mesalamine buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Mesalamine are as follows:

1. United States

*Regulatory Authority*: U.S. Food and Drug Administration (FDA).

*Import Registration Process*: Importers must ensure that Mesalamine is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs or a New Drug Application (NDA) for new drugs.

*Estimated Timeline*: The FDA review process can take approximately 10 months for standard reviews.

*Import Tariff/Duty*: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.

2. Russia

*Regulatory Authority*: Ministry of Health of the Russian Federation.

*Import Registration Process*: Importers must obtain a registration certificate from the Ministry of Health, which involves submitting a dossier including clinical trial data and manufacturing information.

Demand Drivers & Market Opportunity

TransData Nexus Mesalamine buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Mesalamine in importing countries is driven by several factors:

1. Disease Prevalence: Mesalamine is primarily used to treat inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease. The prevalence of IBD has been increasing globally, contributing to higher demand for Mesalamine.

2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the inclusion of Mesalamine in national formularies ensures its availability to patients through public healthcare systems.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including Mesalamine, to meet the needs of the population.

4. WHO Essential Medicines List Procurement: The World Health Organization's Essential Medicines List guides countries in selecting medicines that should be available in their healthcare systems. While Mesalamine is not listed, its therapeutic alternatives are, influencing procurement decisions.

5. Tender-Based Purchasing: Many countries utilize tender systems for procuring medicines, ensuring competitive pricing and consistent supply. For example, Sri Lanka's State Pharmaceuticals Corporation issued a tender for 420,000 tablets of Mesalamine 400mg, closing on March 31, 2026.

The presence of 214 buyers across 51 countries indicates a broad and growing market for Mesalamine, presenting significant opportunities for suppliers to meet the increasing global demand.

TransData Nexus Research · Government and regulatory sources

Common Questions — Mesalamine Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest mesalamine buyer importing from India?

Based on import volume and value, EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) leads with $1.1B in imports and a 81.0% market share — the highest of any single mesalamine importer. SUN PHARMACEUTICAL INDUSTRIES, INC. (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) are the next largest buyers.

QHow many companies buy mesalamine from India?

There are 214 active mesalamine buyers importing from India, with a combined market of $1.3B across 3,779 shipments to 51 countries. The top 5 buyers hold 94.7% of total import value, while the remaining 209 buyers handle the other 5.3%.

QWhich countries import the most mesalamine from India?

The top importing countries for mesalamine from India are United States (98.6%), Russia (0.4%), Algeria (0.3%), Australia (0.2%), Mexico (0.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of mesalamine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for mesalamine from India?

The average import transaction value for mesalamine from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.